Generic medicine
Empagliflozin + Metformin
Empagliflozin + Metformin · Endocrine & metabolic · Antidiabetic medicines
Data statusRegistration & price fields require source verification.
130brands/products
12companies
130with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 500 mg | Tablet | 10s | 110378 | PKR 483.132026-07-23 | PKR 48.31/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 850 mg | Tablet | 30s | 110377 | PKR 1,392.892026-07-23 | PKR 46.43/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 850 mg | Tablet | 14s | 110376 | PKR 560.832026-07-23 | PKR 40.06/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 500 mg | Tablet | 30s | 110378 | PKR 1,421.152026-07-23 | PKR 47.37/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 500 mg | Tablet | 28s | 110375 | PKR 1,281.292026-07-23 | PKR 45.76/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 1000 mg | Tablet | 14s | 110224 | PKR 665.372026-07-23 | PKR 47.53/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 1000 mg | Tablet | 14s | 110374 | PKR 562.242026-07-23 | PKR 40.16/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 500 mg | Tablet | 14s | 110375 | PKR 654.072026-07-23 | PKR 46.72/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 850 mg | Tablet | 14s | 110377 | PKR 663.952026-07-23 | PKR 47.43/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 850 mg | Tablet | 10s | 110377 | PKR 473.242026-07-23 | PKR 47.32/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 500 mg | Tablet | 14s | 110378 | PKR 676.672026-07-23 | PKR 48.33/ tablet |
| Glempa-M | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 850 mg | Tablet | 10s | 110376 | PKR 399.792026-07-23 | PKR 39.98/ tablet |
| Glempa-MXR | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 1000 mg | Tablet | 14's | 118000 | PKR 788.412026-07-23 | PKR 56.32/ tablet |
| Glempa-MXR | Nabiqasim Industries (Pvt) Ltd., | 5 mg + 1000 mg | Tablet | 14's | 118001 | PKR 931.322026-07-23 | PKR 66.52/ tablet |
| Glempa-MXR | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 1000 mg | Tablet | 14's | 118003 | PKR 945.772026-07-23 | PKR 67.56/ tablet |
| Glempa-MXR | Nabiqasim Industries (Pvt) Ltd., | 12.5 mg + 1000 mg | Tablet | 14's | 118002 | PKR 932.932026-07-23 | PKR 66.64/ tablet |
| Schazo-Met | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd. | 12.5 mg + 1000 mg | Tablet | 28's | 113700 | PKR 1,218.592026-07-23 | PKR 43.52/ tablet |
| Schazo-Met | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd. | 12.5 mg + 500 mg | Tablet | 28's | 113701 | PKR 1,197.472026-07-23 | PKR 42.77/ tablet |
| Sciampa-M | Scilife Pharma Private Limited | 5 mg + 850 mg | Tablet | 14's | 112626 | PKR 518.162024-07-01 | PKR 37.01/ tablet |
| Sciampa-M | Scilife Pharma Private Limited | 5 mg + 850 mg | Tablet | 10's | 112626 | PKR 369.372024-07-01 | PKR 36.94/ tablet |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.